Xavier Anglaret

7.5k total citations · 1 hit paper
141 papers, 4.3k citations indexed

About

Xavier Anglaret is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Xavier Anglaret has authored 141 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Infectious Diseases, 62 papers in Epidemiology and 53 papers in Virology. Recurrent topics in Xavier Anglaret's work include HIV/AIDS Research and Interventions (94 papers), HIV Research and Treatment (53 papers) and HIV/AIDS drug development and treatment (46 papers). Xavier Anglaret is often cited by papers focused on HIV/AIDS Research and Interventions (94 papers), HIV Research and Treatment (53 papers) and HIV/AIDS drug development and treatment (46 papers). Xavier Anglaret collaborates with scholars based in France, Ivory Coast and United States. Xavier Anglaret's co-authors include Christine Danel, Delphine Gabillard, Robin Wood, Stephen D Lawn, Anthony Harries, Landon Myer, Roger Salamon, Eugène Messou, Catherine Seyler and Raoul Moh and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

Xavier Anglaret

132 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

2008 511 citations Xavier Anglaret, Robin Wood et al. AIDS profile →

Peers

Countries citing papers authored by Xavier Anglaret

Since Specialization

Citations

This map shows the geographic impact of Xavier Anglaret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Anglaret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Anglaret more than expected).

Fields of papers citing papers by Xavier Anglaret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Anglaret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Anglaret. The network helps show where Xavier Anglaret may publish in the future.

Co-authorship network of co-authors of Xavier Anglaret

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Anglaret. A scholar is included among the top collaborators of Xavier Anglaret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Anglaret. Xavier Anglaret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model 2024 ·BMJ Open ·Amir M. Mohareb, Arthur Y. Kim, Anders Boyd, Farzad Noubary, (unknown), Xavier Anglaret, Patrick Coffié, Serge Eholié, Kenneth A. Freedberg, Emily P. Hyle	0
2	Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis 2022 ·Open Forum Infectious Diseases ·Nathalie De Castro, (unknown), Kévin Jean, (unknown), Rodrigo Escada, (unknown), Eugène Messou, (unknown), Nilesh Bhatt, Celso Khosa, Didier Laureillard, (unknown), Valdiléa G. Veloso, Constance Delaugerre, Xavier Anglaret, Jean‐Michel Molina, (unknown), Olivier Marcy, (unknown)	2
3	Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France) 2022 ·Archives of Public Health ·(unknown), (unknown), Mélanie Plazy, (unknown), (unknown), (unknown), Alexandre Duvignaud, Denis Malvy, Xavier Anglaret, Joanna Orne‐Gliemann, (unknown)	3
4	CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy 2018 ·AIDS Research and Human Retroviruses ·(unknown), Raoul Moh, (unknown), Delphine Gabillard, Xavier Anglaret, Serge Paul Eholié, Fabien Zoulim, Christine Danel, Karine Lacombe, Anders Boyd, (unknown)	3
5	Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa 2014 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Éric Ouattara, Eric L. Ross, Yazdan Yazdanpanah, Angela Y. Wong, Marion Robine, Elena Losina, Raoul Moh, Rochelle P. Walensky, Christine Danel, A. David Paltiel, Serge Eholié, Kenneth A. Freedberg, Xavier Anglaret	5
6	The Survival Benefits of Antiretroviral Therapy in South Africa 2013 ·The Journal of Infectious Diseases ·Michael D. April, Robin Wood, (unknown), A. David Paltiel, Xavier Anglaret, Elena Losina, Kenneth A. Freedberg, Rochelle P. Walensky	38
7	Mortality, AIDS-Morbidity, and Loss to Follow-up by Current CD4 Cell Count Among HIV-1–Infected Adults Receiving Antiretroviral Therapy in Africa and Asia 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Delphine Gabillard, (unknown), Ibra Ndoye, Raoul Moh, Olivier Ségéral, Besigin Tonwe‐Gold, Jean-François Étard, (unknown), (unknown), Serge Eholié, Issouf Konaté, Albert Minga, Eitel Mpoudi‐Ngolé, Sinata Koulla‐Shiro, Djimon Marcel Zannou, Xavier Anglaret, Christian Laurent	39
8	CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters 2011 ·AIDS ·Albert Minga, (unknown), Delphine Gabillard, (unknown), (unknown), Arlette Emième, (unknown), André Inwoley, Roger Salamon, Xavier Anglaret	9
9	Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-Effectiveness 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·April D. Kimmel, Milton C. Weinstein, Xavier Anglaret, Sue J. Goldie, Elena Losina, Yazdan Yazdanpanah, Eugène Messou, (unknown), Rochelle P. Walensky, Kenneth A. Freedberg	40
10	Scaling Up Antiretroviral Therapy for HIV-Infected Children in Cote d'Ivoire: Determinants of Survival and Loss to programme/Elargissement Du Traitement Antiretroviral Pour Les Enfants Infectes Par le VIH En Cote d'Ivoire: Determinants De la Survie et Des Pertes Pour le programme/Expansion del Tratamiento Antirretroviral Entre Ninos Infectados Por El VIH En Cote d'Ivoire: 2010 ·Bulletin of the World Health Organization ·(unknown), (unknown), (unknown), (unknown), (unknown), S. Touré, Catherine Seyler, Patricia Fassinou, (unknown), (unknown), Xavier Anglaret, Valériane Leroy	2
11	Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal 2009 ·PLoS Medicine ·Elena Losina, (unknown), Lauren M. Uhler, Xavier Anglaret, A. David Paltiel, Éric Balestre, Rochelle P. Walensky, Eugène Messou, Milton C. Weinstein, François Dabis, Kenneth A. Freedberg, (unknown)	60
12	Medium-Term Probability of Success of Antiretroviral Treatment after Early Warning Signs of Treatment Failure in West African Adults 2009 ·AIDS Research and Human Retroviruses ·Christine Danel, Delphine Gabillard, André Inwoley, Marie‐Laure Chaix, Thomas d’Aquin Toni, Raoul Moh, Eugène Messou, E. Bissagnené, Roger Salamon, Serge Eholié, Xavier Anglaret	7
13	Variation of CD4 Count and Percentage during Pregnancy and after Delivery: Implications for HAART Initiation in Resource-Limited Settings 2007 ·AIDS Research and Human Retroviruses ·Didier Koumavi Ekouévi, André Inwoley, Besigin Tonwe‐Gold, Christine Danel, Renaud Becquet, Ida Viho, François Rouet, François Dabis, Xavier Anglaret, Valériane Leroy	32
14	Short Communication: Lack of Indinavir-Associated Nephrological Complications in HIV-Infected Adults (Predominantly Women) with High Indinavir Plasma Concentration in Abidjan, Côte d'Ivoire 2007 ·AIDS Research and Human Retroviruses ·Christine Danel, Raoul Moh, Gilles Peytavin, Amani Anzian, Albert Minga, (unknown), (unknown), (unknown), Delphine Gabillard, Roger Salamon, E. Bissagnené, Xavier Anglaret	1
15	Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d’Ivoire: impact of alternative methods of CD4 count modelling 2007 ·European Journal of Epidemiology ·Sylvie Deuffic‐Burban, Elena Losina, Bingxia Wang, (unknown), (unknown), (unknown), Kenneth A. Freedberg, Xavier Anglaret, Yazdan Yazdanpanah	15
16	Risk Factors for Active Tuberculosis after Antiretroviral Treatment Initiation in Abidjan 2005 ·American Journal of Respiratory and Critical Care Medicine ·Catherine Seyler, Siaka Touré, Eugène Messou, Dominique Bonard, Delphine Gabillard, Xavier Anglaret	84
17	Épidémie de sida en Afrique subsaharienne 2004 ·médecine/sciences ·Xavier Anglaret, Roger Salamon	6
18	Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire 2003 ·AIDS ·Xavier Anglaret, Eugène Messou, Timothée Ouassa, Siaka Touré, Nicole Dakoury-Dogbo, P Combe, Alassan Kouamé Mahassadi, Catherine Seyler, Thérèse N’Dri-Yoman, Roger Salamon	63
19	Troubles alimentaires ressentis par des adultes infectés par le virus de l’immunodéficience humaine à Abidjan (Côte d’Ivoire) 2000 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·Katia Castetbon, Alain Attia, Xavier Anglaret, Thérèse N’Dri-Yoman, Fatoumata Sylla‐Koko, Denis Malvy, (unknown)	1
20	Chimioprophylaxie primaire de la tuberculose chez les personnes infectées par le VIH dans les pays non industrialisés 1997 ·Cahiers d'études et de recherches francophones / Santé ·Xavier Anglaret, François Dabis, J Batungwanayo, Christian Perronne, Henri Taelman, Dominique Bonard, Fatoumata Sylla‐Koko, Valériane Leroy, Philippe Van de Perre, Jean‐Louis Vildé, Roger Salamon	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact